Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide. (Q53269007)
Jump to navigation
Jump to search
scientific article published in April 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide. |
scientific article published in April 2005 |
Statements
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide. (English)
Harald Hampel
1 reference
Stefan J Teipel
1 reference
Hans-Jürgen Möller
1 reference
Richard Dodel
Sylvia Brettschneider
Nils G Morgenthaler
Christina Fischer-Schulz
Katharina Bürger
Yansheng Du
Andreas Bergmann
1 April 2005
57
7
813-816